Research and Markets: Atopic Dermatitis Pipeline Highlights Report 2014-2017

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/6jpzsw/atopic_dermatitis) has announced the addition of the "Atopic Dermatitis Pipeline Highlights - 2015" report to their offering.

The latest report Atopic Dermatitis Pipeline Highlights - 2015, provides most up-to-date information on key pipeline molecules in the global Atopic Dermatitis market. It covers emerging therapies for Atopic Dermatitis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Atopic Dermatitis pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Atopic Dermatitis pipeline molecules by their dominant mechanism of action. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Atopic Dermatitis pipeline molecules by the Originator Company.

Short-term Launch Highlights:

Find out which Atopic Dermatitis pipeline products will be launched in the US and Ex-US till 2017.

Key Topics Covered:

1. Atopic Dermatitis Pipeline by Stages

2. Atopic Dermatitis Pipeline by Drug Class

3. Atopic Dermatitis Pipeline by Company

4. Atopic Dermatitis Phase 3 Clinical Trial Insights

5. Atopic Dermatitis Phase 2 Clinical Trial Insights

6. Atopic Dermatitis Phase 1 Clinical Trial Insights

7. Atopic Dermatitis Preclinical Research Insights

8. Atopic Dermatitis Discovery Stage Insights

9. Appendix

10. Research Methodology

For more information visit http://www.researchandmarkets.com/research/6jpzsw/atopic_dermatitis

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals